AU2001235970A1 - Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation - Google Patents

Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Info

Publication number
AU2001235970A1
AU2001235970A1 AU2001235970A AU3597001A AU2001235970A1 AU 2001235970 A1 AU2001235970 A1 AU 2001235970A1 AU 2001235970 A AU2001235970 A AU 2001235970A AU 3597001 A AU3597001 A AU 3597001A AU 2001235970 A1 AU2001235970 A1 AU 2001235970A1
Authority
AU
Australia
Prior art keywords
preparation
polymorphic forms
novel crystalline
crystalline polymorphic
venlafaxine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235970A
Inventor
Siva Lakshmi Devi Arikatla
Om Reddy Gaddam
Vyas Krishnamurthi
Mahender Rao Siripragada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Publication of AU2001235970A1 publication Critical patent/AU2001235970A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
AU2001235970A 2000-12-07 2000-12-07 Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation Abandoned AU2001235970A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000121 WO2002046140A1 (en) 2000-12-07 2000-12-07 Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Publications (1)

Publication Number Publication Date
AU2001235970A1 true AU2001235970A1 (en) 2002-06-18

Family

ID=11076286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235970A Abandoned AU2001235970A1 (en) 2000-12-07 2000-12-07 Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Country Status (2)

Country Link
AU (1) AU2001235970A1 (en)
WO (1) WO2002046140A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031298A3 (en) 2000-10-19 2003-10-15 Teva Pharmaceutical Industries Ltd. Process for preparing venlafaxine crystalline base and novel venlafaxine hydrochloride polymorphs
US20020183553A1 (en) 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
CA2426393C (en) 2000-10-31 2012-05-29 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
BR0214742A (en) 2001-12-05 2004-09-14 Wyeth Corp Venlafaxine hydrochloride crystalline polymorph and methods for its preparation
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
MY160607A (en) * 2010-10-01 2017-03-15 Shan Dong Luye Pharm Co Ltd Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl) ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
CN113831252A (en) * 2020-06-24 2021-12-24 中国医学科学院药物研究所 Venlafaxine caffeate and preparation method, composition and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56324B1 (en) * 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor

Also Published As

Publication number Publication date
WO2002046140A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
EP1463711A4 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
AU1386301A (en) Polymorphic forms of sertraline hydrochloride
IL164648A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
AU2001256595A1 (en) Novel amorphous form of sertraline hydrochloride
WO2000004016A3 (en) Polymorph of ritonavir
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
HUP0700037A2 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AU2003230195A1 (en) A novel process for amorphous form of donepezil hydrochloride
AU2003292452A1 (en) A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
HUP0103702A3 (en) Polymorphic crystalline forms of 1-pyrrole derivatives and process for their preparation
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
AU2002308986A1 (en) Process for preparation of a quinolinecarbaldehyde
AU2003243153A1 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002213477A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
AU2003274608A1 (en) Process for preparation of polymorphic form of sertraline hydrochloride
AU1724201A (en) Process for the preparation of fluoxetine hydrochloride
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
AU5065001A (en) Process for producing alpha-l-aspartyl-l-phenylalanine methylester hydrochloride
AU4798400A (en) Process for crystallizing (r)-fluoxetine hydrochloride
AU2002217420A1 (en) Process for the preparation of crystalline polymorph ii of lamivudine